29452

    544350

    AGARWALEYE

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    DR AGARWALS HEALTH CARE L Share Price Today

    DR AGARWALS HEALTH CARE L is currently trading at ₹478, down by ₹4.2 from the previous close. The stock touched an intraday high of ₹490.00 and a low of ₹473.95 during the latest trading session. Over the past one year, DR AGARWALS HEALTH CARE L has delivered a return of 4.62%, while the stock has declined 0.19% in the last one month.

    DR AGARWALS HEALTH CARE L performance

    Today’s low Today’s high
    ₹ 473.95 ₹ 490.00
    ₹ 478.00
    52 week low 52 week high
    ₹ 401.00 ₹ 568.00
    ₹ 478.00
    Open Price ₹ 481.50
    Prev. Close ₹ 482.20
    Volume (Shares) 43758.00
    Total traded value ₹ 209.16
    Upper Circuit ₹ 578.60
    Lower Circuit ₹ 385.80
    info

    Investment Returns

    Over 1 Month -0.19% Over 3 Months 7.39% Over 6 Months 7.88% Over 1 Year 4.62%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    DR AGARWALS HEALTH CARE L fundamentals


    • Market cap (Cr) 15,153.90
    • P/E Ratio (TTM) 386.37
    • Beta 0.20
    • Book Value / share 62.81
    • Return on equity 1.25%
    • EPS (TTM) 1.36
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 10.60
    info icon alternate text
    • Market cap (Cr) 15,188.70
    • P/E Ratio (TTM) 386.37
    • Beta 0.22
    • Book Value / share 62.81
    • Return on equity 1.25%
    • EPS (TTM) 1.36
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 10.60
    info icon alternate text

    DR AGARWALS HEALTH CARE L Financials

    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 347.86
    Operating Expense 330.75
    Net Profit 10.60
    Net Profit Margin (%) 3.04
    Earnings Per Share (EPS) 0.33
    EBITDA 93.17
    Effective Tax Rate (%) 42.42
    Particulars DEC 2025 (Values in Cr)
    Revenue 334.84
    Operating Expense 320.84
    Net Profit 14.06
    Net Profit Margin (%) 4.19
    Earnings Per Share (EPS) 0.44
    EBITDA 86.44
    Effective Tax Rate (%) 31.07
    Particulars SEP 2025 (Values in Cr)
    Revenue 308.98
    Operating Expense 305.51
    Net Profit 4.68
    Net Profit Margin (%) 1.51
    Earnings Per Share (EPS) 0.15
    EBITDA 74.95
    Effective Tax Rate (%) 51.04
    Particulars JUN 2025 (Values in Cr)
    Revenue 301.72
    Operating Expense 298.45
    Net Profit 10.11
    Net Profit Margin (%) 3.35
    Earnings Per Share (EPS) 0.32
    EBITDA 79.12
    Effective Tax Rate (%) 35.15
    Particulars MAR 2025 (Values in Cr)
    Revenue 281.02
    Operating Expense 270.69
    Net Profit 26.51
    Net Profit Margin (%) 9.43
    Earnings Per Share (EPS) 0.85
    EBITDA 97.15
    Effective Tax Rate (%) 22.14
    Particulars MAR 2026 (Values in Cr)
    Revenue 1293.39
    Operating Expense 1255.54
    Net Profit 39.45
    Net Profit Margin (%) 3.05
    Earnings Per Share (EPS) 1.25
    EBITDA 333.68
    Effective Tax Rate (%) 38.32
    Particulars MAR 2025 (Values in Cr)
    Revenue 1043.89
    Operating Expense 1045.10
    Net Profit 21.93
    Net Profit Margin (%) 2.10
    Earnings Per Share (EPS) 0.74
    EBITDA 284.90
    Effective Tax Rate (%) 43.18
    Particulars MAR 2024 (Values in Cr)
    Revenue 835.06
    Operating Expense 828.39
    Net Profit 23.83
    Net Profit Margin (%) 2.85
    Earnings Per Share (EPS) 25.55
    EBITDA 259.09
    Effective Tax Rate (%) 46.64
    Particulars MAR 2023 (Values in Cr)
    Revenue 597.64
    Operating Expense 591.98
    Net Profit 31.59
    Net Profit Margin (%) 5.28
    Earnings Per Share (EPS) 39.83
    EBITDA 147.78
    Effective Tax Rate (%) 640.92
    Particulars MAR 2022 (Values in Cr)
    Revenue 361.59
    Operating Expense 372.90
    Net Profit -1.47
    Net Profit Margin (%) -0.40
    Earnings Per Share (EPS) -2.15
    EBITDA 94.91
    Effective Tax Rate (%) -54.73
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 59.09
    ROE % 6.46
    ROCE % 9.27
    Total Debt to Total Equity 0.60
    EBITDA Margin 29.56
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 1435.56
    ROE % 7.45
    ROCE % 10.39
    Total Debt to Total Equity 0.93
    EBITDA Margin 29.02
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 794.29
    ROE % 18.14
    ROCE % 11.67
    Total Debt to Total Equity 1.77
    EBITDA Margin 28.33
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 309.59
    ROE % 14.67
    ROCE % 12.50
    Total Debt to Total Equity 2.06
    EBITDA Margin 29.22
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 268.57
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.80
    EBITDA Margin 19.20
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 61.21
    ROE % 1.25
    ROCE % 5.34
    Total Debt to Total Equity 0.39
    EBITDA Margin 27.64
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 1315.31
    ROE % 1.44
    ROCE % 6.43
    Total Debt to Total Equity 0.70
    EBITDA Margin 29.52
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 708.15
    ROE % 11.95
    ROCE % 8.10
    Total Debt to Total Equity 1.11
    EBITDA Margin 29.24
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 289.96
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 1.03
    EBITDA Margin 26.69
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 293.27
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.66
    EBITDA Margin 15.76
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 258.13
    Total Assets 3671.57
    Total Liabilities 3671.57
    Total Equity 1926.82
    Share Outstanding 31
    Price to Book Ratio 7.30
    Return on Assets (%) 2.27
    Return on Capital (%) 3.84
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 124.87
    Total Assets 2752.82
    Total Liabilities 2752.82
    Total Equity 1379.51
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 3.01
    Return on Capital (%) 4.7
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 148.53
    Total Assets 1825.17
    Total Liabilities 1825.17
    Total Equity 659.07
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 5.15
    Return on Capital (%) 9.27
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 116.68
    Total Assets 1026.13
    Total Liabilities 1026.13
    Total Equity 233.82
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 3.67
    Return on Capital (%) 7.19
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 64.94
    Total Assets 786.98
    Total Liabilities 786.98
    Total Equity 198.69
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -7.04
    Return on Capital (%) -14.54
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 193.96
    Total Assets 2836.77
    Total Liabilities 2836.77
    Total Equity 1933.64
    Share Outstanding 31
    Price to Book Ratio 7.30
    Return on Assets (%) 0.77
    Return on Capital (%) 1.05
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 63.37
    Total Assets 2186.94
    Total Liabilities 2186.94
    Total Equity 1227.21
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 1.08
    Return on Capital (%) 1.53
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 97.48
    Total Assets 1387.58
    Total Liabilities 1387.58
    Total Equity 561.56
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 2.27
    Return on Capital (%) 3.64
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 60.00
    Total Assets 692.45
    Total Liabilities 692.45
    Total Equity 198.91
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -0.21
    Return on Capital (%) -0.33
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 32.77
    Total Assets 643.38
    Total Liabilities 643.38
    Total Equity 201.18
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -8.40
    Return on Capital (%) -14.94
    Particulars MAR 2025 (Values in Cr)
    Net Income 159.85
    Cash from Operations 396.93
    Cash from Investing -750.33
    Cash from Financing 381.86
    Net change in Cash -8.14
    Free Cash Flow 717.82
    Particulars MAR 2024 (Values in Cr)
    Net Income 140.57
    Cash from Operations 378.08
    Cash from Investing -913.91
    Cash from Financing 552.68
    Net change in Cash -15.23
    Free Cash Flow 610.41
    Particulars MAR 2023 (Values in Cr)
    Net Income 83.59
    Cash from Operations 268.48
    Cash from Investing -509.08
    Cash from Financing 303.33
    Net change in Cash 27.36
    Free Cash Flow 426.29
    Particulars MAR 2022 (Values in Cr)
    Net Income 56.76
    Cash from Operations 179.92
    Cash from Investing -155.35
    Cash from Financing 35.43
    Net change in Cash 44.41
    Free Cash Flow 250.51
    Particulars MAR 2021 (Values in Cr)
    Net Income -48.35
    Cash from Operations 106.65
    Cash from Investing -36.56
    Cash from Financing -37.10
    Net change in Cash 16.55
    Free Cash Flow 233.20
    Particulars MAR 2025 (Values in Cr)
    Net Income 38.60
    Cash from Operations 201.66
    Cash from Investing -577.46
    Cash from Financing 374.08
    Net change in Cash 4.62
    Free Cash Flow 384.51
    Particulars MAR 2024 (Values in Cr)
    Net Income 44.66
    Cash from Operations 234.55
    Cash from Investing -817.60
    Cash from Financing 570.41
    Net change in Cash -25.61
    Free Cash Flow 368.61
    Particulars MAR 2023 (Values in Cr)
    Net Income -5.84
    Cash from Operations 164.97
    Cash from Investing -435.57
    Cash from Financing 315.94
    Net change in Cash 33.06
    Free Cash Flow 241.43
    Particulars MAR 2022 (Values in Cr)
    Net Income -0.95
    Cash from Operations 86.20
    Cash from Investing -98.43
    Cash from Financing 40.16
    Net change in Cash 20.03
    Free Cash Flow 164.48
    Particulars MAR 2021 (Values in Cr)
    Net Income -52.18
    Cash from Operations 51.20
    Cash from Investing -26.44
    Cash from Financing -21.11
    Net change in Cash -1.27
    Free Cash Flow 74.42
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8955.00 65.82 13.59 128759.16 6680.00 9099.95
    FORTIS MALAR HOSPITALS LIMITED 50.61 22.90 2.76 94.85 40.75 76.00
    SHREE PACETRONIX LTD. 137.05 16.35 2.88 51.39 71.00 283.15
    TRANSGENE BIOTEK LTD. 3.01 0.00 2.72 22.81 1.83 5.17
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8955.00 85.77 12.92 128759.16 6680.00 9099.95
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 36.05 0.00 -8.77 26.93 30.30 57.48
    KOVAI MEDICAL CENTER & HO 5916.50 26.30 4.90 6472.65 5010.00 6725.00

    DR AGARWALS HEALTH CARE L shareholding pattern

    Holding
    1.97%
    32.33%
    57.96%
    7.72%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    DR AGARWALS HEALTH CARE L Technicals Summary

    478.00 -0.87 redarrow
    red-green-graph indicator
    10 Bearish
    6 Bullish
    • 5 Days 482.40
    • 26 Days 480.00
    • 10 Days 483.00
    • 50 Days 473.60
    • 12 Days 483.00
    • 100 Days 467.00
    • 20 Days 481.60
    • 200 Days 459.00
    486.38 PIVOT
    First Support 475.92 First Resistance 492.67 Second Support 469.63 Second Resistance 503.13 Third Support 459.17 Third Resistance 509.42
    RSI 48.77 ADX 11.00 MACD 2.98 Williams % R -77.14 Commodity Channel Index (CCI) -52.37
    Date 2026-07-31 Week 48639.00 Same Day 27994.00 Month 44920.00
    1 Year 0.21 3 Year 0.30
    Over 1 Month
    -0.19% down
    Over 1 Year
    4.62% down
    Over 3 Months
    7.39% down
    Over 3 Years
    0.00% down
    Over 6 Months
    7.88% down
    Over 5 Years
    0.00% down

    DR AGARWALS HEALTH CARE L Corporate Actions

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Dr Agarwals Health Care Ltd?

    Answer Field

    Dr Agarwals Health Care Ltd share price is for NSE ₹ 478.00 & for BSE ₹ 479.10 as on Jul 31 2026 03:30 PM.

    What is the Market Cap of Dr Agarwals Health Care Ltd Share?

    Answer Field

    The market cap of Dr Agarwals Health Care Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 31 2026 03:30 PM.

    What is the 52 Week High and Low of Dr Agarwals Health Care Ltd?

    Answer Field

    The 52 Week High and Low of Dr Agarwals Health Care Ltd for NSE is ₹ 568.00 and ₹ 401.00 and for BSE is ₹ 567.80 and ₹ 402.10.

    What is 1 year return for Dr Agarwals Health Care Ltd?

    Answer Field

    The 1 year returns on the stock has been 4.62%.

    What is the P/E Ratio of Dr Agarwals Health Care Ltd Share?

    Answer Field

    As on Jul 31 2026 03:30 PM the price-to-earnings (PE) ratio for Dr Agarwals Health Care Ltd share is 386.37.

    What is the PB ratio of Dr Agarwals Health Care Ltd Share?

    Answer Field

    As on Jul 31 2026 03:30 PM, the price-to-book (PB) ratio for Dr Agarwals Health Care Ltd share is 62.81.

    How to Buy Dr Agarwals Health Care Ltd Share?

    Answer Field

    You can trade in Dr Agarwals Health Care Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Dr Agarwals Health Care Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Dr Agarwals Health Care Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Dr Agarwals Health Care Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |